Cargando…

A New Public Health Tool for Risk Assessment of Abnormal Glucose Levels

INTRODUCTION: Self-reported prediabetes and diabetes rates underestimate true prevalence, but mass laboratory screening is generally impractical for risk assessment and surveillance. We developed the Abnormal Glucose Risk Assessment-6 (AGRA-6) tool to address this problem. METHODS: Self-report data...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Guozhong, Sentell, Tetine, Schillinger, Dean
Formato: Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2831788/
https://www.ncbi.nlm.nih.gov/pubmed/20158962
_version_ 1782178266472251392
author He, Guozhong
Sentell, Tetine
Schillinger, Dean
author_facet He, Guozhong
Sentell, Tetine
Schillinger, Dean
author_sort He, Guozhong
collection PubMed
description INTRODUCTION: Self-reported prediabetes and diabetes rates underestimate true prevalence, but mass laboratory screening is generally impractical for risk assessment and surveillance. We developed the Abnormal Glucose Risk Assessment-6 (AGRA-6) tool to address this problem. METHODS: Self-report data were obtained from the 1,887 adults (18 years or older) in the National Health and Nutrition Examination Survey (NHANES) 2005-2006 with fasting plasma glucose and oral glucose tolerance tests. We created AGRA-6 models by using logistic regression. Performance was validated with NHANES 2005-2006 data by using leave-1-out cross-validation. Standard performance characteristics (sensitivity, specificity, predictive values, area under receiver-operating characteristic curves) were assessed, as was the potential efficiency of the models to reduce laboratory testing in screening efforts. RESULTS: Performance was good for all models under testing conditions. Use of the AGRA-6 in screening efforts could reduce laboratory testing by at least 30% when sensitivity is maximized and at least 52% when sensitivity and specificity are balanced. CONCLUSION: The AGRA-6 appears to be an effective, feasible tool that uses self-reported data compatible with the Behavioral Risk Factor Surveillance System to assess population-level prevalence, identify abnormal glucose levels, optimize screening efforts, and focus interventions to reduce the prevalence of abnormal glucose levels.
format Text
id pubmed-2831788
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Centers for Disease Control and Prevention
record_format MEDLINE/PubMed
spelling pubmed-28317882010-03-25 A New Public Health Tool for Risk Assessment of Abnormal Glucose Levels He, Guozhong Sentell, Tetine Schillinger, Dean Prev Chronic Dis Original Research INTRODUCTION: Self-reported prediabetes and diabetes rates underestimate true prevalence, but mass laboratory screening is generally impractical for risk assessment and surveillance. We developed the Abnormal Glucose Risk Assessment-6 (AGRA-6) tool to address this problem. METHODS: Self-report data were obtained from the 1,887 adults (18 years or older) in the National Health and Nutrition Examination Survey (NHANES) 2005-2006 with fasting plasma glucose and oral glucose tolerance tests. We created AGRA-6 models by using logistic regression. Performance was validated with NHANES 2005-2006 data by using leave-1-out cross-validation. Standard performance characteristics (sensitivity, specificity, predictive values, area under receiver-operating characteristic curves) were assessed, as was the potential efficiency of the models to reduce laboratory testing in screening efforts. RESULTS: Performance was good for all models under testing conditions. Use of the AGRA-6 in screening efforts could reduce laboratory testing by at least 30% when sensitivity is maximized and at least 52% when sensitivity and specificity are balanced. CONCLUSION: The AGRA-6 appears to be an effective, feasible tool that uses self-reported data compatible with the Behavioral Risk Factor Surveillance System to assess population-level prevalence, identify abnormal glucose levels, optimize screening efforts, and focus interventions to reduce the prevalence of abnormal glucose levels. Centers for Disease Control and Prevention 2010-02-15 /pmc/articles/PMC2831788/ /pubmed/20158962 Text en https://creativecommons.org/licenses/by/4.0/This is a publication of the U.S. Government. This publication is in the public domain and is therefore without copyright. All text from this work may be reprinted freely. Use of these materials should be properly cited.
spellingShingle Original Research
He, Guozhong
Sentell, Tetine
Schillinger, Dean
A New Public Health Tool for Risk Assessment of Abnormal Glucose Levels
title A New Public Health Tool for Risk Assessment of Abnormal Glucose Levels
title_full A New Public Health Tool for Risk Assessment of Abnormal Glucose Levels
title_fullStr A New Public Health Tool for Risk Assessment of Abnormal Glucose Levels
title_full_unstemmed A New Public Health Tool for Risk Assessment of Abnormal Glucose Levels
title_short A New Public Health Tool for Risk Assessment of Abnormal Glucose Levels
title_sort new public health tool for risk assessment of abnormal glucose levels
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2831788/
https://www.ncbi.nlm.nih.gov/pubmed/20158962
work_keys_str_mv AT heguozhong anewpublichealthtoolforriskassessmentofabnormalglucoselevels
AT sentelltetine anewpublichealthtoolforriskassessmentofabnormalglucoselevels
AT schillingerdean anewpublichealthtoolforriskassessmentofabnormalglucoselevels
AT heguozhong newpublichealthtoolforriskassessmentofabnormalglucoselevels
AT sentelltetine newpublichealthtoolforriskassessmentofabnormalglucoselevels
AT schillingerdean newpublichealthtoolforriskassessmentofabnormalglucoselevels